Details

NameSymbolSector
GENPHARMASEC LIMITEDGENPHARMATrading & Distributors
Open
1.29
High
1.33
Low
1.27
Close
1.3
Volume
428693
Exchange
bse
Time
28-Apr-2026

Outlook

Score:  

2.25

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Genpharmasec is  
Short Body
Estimated Stoploss of Genpharmasec is ₹  
1.27
Genpharmasec has a  
Bullishℹ
 pattern. 
Formation of  
Short Body
 candle pattern indicates the trend direction of Genpharmasec is  
Unpredictableℹ
. 

Trend

Genpharmasec is in  
Sideways trendℹ
. 
Price of Genpharmasec is  
Upℹ
 by  

16.07

%. 
Target
Buy @ 

0.88

Sell @ 

1.42

Current @ 

1.3

Volume

The trade volumes of Genpharmasec have become  
Deficientℹ
Though the volume trend for Genpharmasec appears  
Bullishℹ
 the participants seem to be  
Weak Buyersℹ
The trade volume of Genpharmasec is  

Down

 by  

70.7

% 

Valuation

The current market price of Genpharmasec is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 79cr and total assets worth ₹ 79cr, the balance sheet of Genpharmasec is:  
Balancedℹ
. 
Cashflow
Genpharmasec has  
Poorℹ
 cash flow because there is  

Shortage

 of  

₹ 13cr

. It is  
Downℹ
 by  

181.25

%. 

(*Mar 2025)

11.11% i.e. ₹ 2cr earned in operatingℹ
83.33% i.e. ₹ 15cr spent in investingℹ
5.56% i.e. ₹ 1cr spent in financingℹ
0% in otherℹ
Genpharmasec has  
Sufficientℹ
 cash flow because there is  

Surplus

 of  

₹ 16cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2024)

2.6% i.e. ₹ 2cr spent in operatingℹ
36.36% i.e. ₹ 28cr spent in investingℹ
61.04% i.e. ₹ 47cr earned in financingℹ
0% in otherℹ
Income
The income of Genpharmasec is  

₹ 33cr

 and  

Loss

 is :  

₹ 1cr

(*Sep 2025)

Genpharmasec Losses increased by:  

200

% and Income is Up by:  

175

% 

(*Sep 2025)

The income of Genpharmasec is  

₹ 12cr

 and  

Profit

 is :  

₹ 1cr

(*Jun 2025)

Genpharmasec Profit is up by:  

100

% and Income is Down by:  

14.29

% 

(*Jun 2025)

The income of Genpharmasec is  

₹ 14cr

 and  

Loss

 is :  

₹ 0cr

(*Mar 2025)

Genpharmasec Losses increased by:  

0

% and Income is Up by:  

55.56

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.